Measles vaccine is a vaccine that prevents measles. After one dose 85% of children nine months of age and 95% over twelve months of age are immune. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When rates of vaccination within a population are greater than ~92% outbreaks of measles typically no longer occur; however, they may occur again if rates of vaccination decrease. The vaccine's effectiveness lasts many years.

Property Value
dbo:abstract
  • Measles vaccine is a vaccine that prevents measles. After one dose 85% of children nine months of age and 95% over twelve months of age are immune. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When rates of vaccination within a population are greater than ~92% outbreaks of measles typically no longer occur; however, they may occur again if rates of vaccination decrease. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days of exposure to measles.The vaccine is generally safe including in those with HIV infections. Side effects are usually mild and short lived. This may include pain at the site of injection or mild fever. Anaphylaxis has been documented in about 3.5–10 cases per million doses. Rates of Guillain–Barré syndrome, autism and inflammatory bowel disease do not appear to be increased.The vaccine is available both by itself and in combination with other vaccines. This includes with the rubella vaccine and mumps vaccine to make the MMR vaccine, first made available in 1971. The addition of the varicella vaccine against chickenpox to these three in 2005 gave the MMRV vaccine. The vaccine works equally well in all formulations. The World Health Organization recommends it be given at nine months of age in areas of the world where the disease is common, or at twelve months where the disease is not common. It is a vaccine based on a live but weakened strain of measles. It comes as a dried powder which is mixed with a specific liquid before being injected either just under the skin or into a muscle. Verification that the vaccine was effective can be determined by blood tests.About 85% of children globally have received this vaccine as of 2013. In 2015, at least 160 countries provided two doses in their routine immunization. It was first introduced in 1963. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about 0.70 USD per dose as of 2014. (en)
dbo:medlinePlus
  • a601176
dbo:thumbnail
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2018-05-03 20:14:43Z (xsd:date)
  • 2019-04-21 01:42:41Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 21053550 (xsd:integer)
dbo:wikiPageLength
  • 27130 (xsd:integer)
  • 27772 (xsd:integer)
dbo:wikiPageModified
  • 2018-04-20 18:05:24Z (xsd:date)
  • 2019-04-21 01:33:07Z (xsd:date)
dbo:wikiPageOutDegree
  • 63 (xsd:integer)
  • 64 (xsd:integer)
dbo:wikiPageRevisionID
  • 837417615 (xsd:integer)
  • 893394751 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:atcPrefix
  • J07 (en)
dbp:atcSuffix
  • BD01 (en)
dbp:caption
  • A child is given a measles vaccine. (en)
dbp:chemspiderid
  • none (en)
dbp:date
  • April 2018 (en)
dbp:medlineplus
  • a601176 (en)
dbp:reason
  • A reference is needed showing that the MMR vaccine used Attenuvax at some past point. (en)
  • This needs updating in light of the subsequent sentence stating that Attenuvax was discontinued in 2009. (en)
dbp:target
dbp:type
  • vaccine (en)
dbp:vaccineType
  • Attenuated (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 446097921 (xsd:integer)
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Measles vaccine is a vaccine that prevents measles. After one dose 85% of children nine months of age and 95% over twelve months of age are immune. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When rates of vaccination within a population are greater than ~92% outbreaks of measles typically no longer occur; however, they may occur again if rates of vaccination decrease. The vaccine's effectiveness lasts many years. (en)
rdfs:label
  • Measles vaccine (en)
owl:sameAs
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of